ReviewCureus2020
Endocrinological Manifestations of Sanjad-Sakati Syndrome.
Review in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Clinical and genetic insights into Autosomal Dominant Hypocalcemia type 1: a single-center case series including genotype-phenotype correlations, pregnancy outcomes, and novel CASR variants.Journal of endocrinological investigation · 2026Article
- Sanjad-Sakati Syndrome in Jordan: Clinical Features, Comorbidities, and Mortality Rate.Avicenna journal of medicine · 2026Article
- Hypercalciuria in Sanjad-Sakati Syndrome: A Retrospective Evaluation of Kidney Involvement Indicators.Cureus · 2026Article
- Sanjad-Sakati syndrome: integrated emergency care, long-term management, and expert perspectives-a narrative review.Frontiers in pediatrics · 2026Review
- Kenny-Caffey Syndrome Type 2 (KCS2): A New Case Report and Patient Follow-Up Optimization.Journal of clinical medicine · 2024Article
- HomozygousJournal of pediatric genetics · 2024Article
- Article
- Sanjad-Sakati Syndrome in a 35-day-old Iraqi Infant: A Case Report.Oman medical journal · 2024Article
- Assessing the Need for Pediatric Palliative Care in the Six Arab Gulf Cooperation Council Countries.Palliative medicine reports · 2023Article
- Sanjad Sakati syndrome and sleep-disordered breathing: an undisclosed association.Sleep & breathing = Schlaf & Atmung · 2022Article
- Oral Facial Manifestations of Sanjad-Sakati Syndrome: A Literature Review.Children (Basel, Switzerland) · 2022Review
- A Staghorn Calcium Phosphate Stone in a Child With Sanjad-Sakati Syndrome: An Iatrogenic Manifestation?Cureus · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sanjad-Sakati syndrome (SSS), also known as hypoparathyroidism-retardation-dysmorphism (HRD) syndrome, is a very rare genetic disorder with an autosomal recessive mode of inheritance, mostly seen in children of Middle Eastern origin. Hypoparathyroidism remains the most characteristic endocrinological feature of SSS; but not the only one. This review outlines and elucidates other endocrinological manifestations that may be seen with this syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.